ARGOBIO
Argobio Studio is a biotech start-up studio that builds therapeutics-based companies by leveraging breakthrough science. It raises funding to support disruptive translational research projects from early stages through company creation and Series A financing. Operating primarily in France and the UK, Argobio collaborates closely with academic research teams and CROs to mature projects through translational work, preclinical testing, toxicology, and manufacturing. The studio focuses on creating a diverse pipeline of therapeutic indications and modalities, providing operational excellence and experienced scientific and entrepreneurial teams to early-stage projects. Argobio has successfully launched companies such as Elkedonia and Enodia Therapeutics, and partners with leading European investors to support its portfolio.
ARGOBIO
Argobio Studio is a biotech start-up studio that builds therapeutics-based companies by leveraging breakthrough science. It raises funding to support disruptive translational research projects from early stages through company creation and Series A financing. Operating primarily in France and the UK, Argobio collaborates closely with academic research teams and CROs to mature projects through translational work, preclinical testing, toxicology, and manufacturing. The studio focuses on creating a diverse pipeline of therapeutic indications and modalities, providing operational excellence and experienced scientific and entrepreneurial teams to early-stage projects. Argobio has successfully launched companies such as Elkedonia and Enodia Therapeutics, and partners with leading European investors to support its portfolio.